Background And Purpose: Recombinant tissue plasminogen activator is used for the treatment of acute myocardial infarction, pulmonary embolism, and acute ischemic stroke. With many years since approval of the drug and an aging population, chances increase that patients are treated twice for chronologically separated events.
Methods: We identified patients from the prospective Erlangen Stroke and Thrombolysis Database who received repeated thrombolysis for acute ischemic stroke. Baseline demographic data and clinical, laboratory, and imaging findings were analyzed. Functional outcome was assessed after 3 months.
Results: Eight patients treated twice and one patient with 3 treatments were identified. The median time span between first and second thrombolysis was 10 (3 to 48) months. All patients had a favorable outcome after the first treatment, and 67% of patients had a favorable outcome after the second thrombolysis. Neither allergic reactions nor other immunoreactive events were observed.
Conclusions: Repeated administration of recombinant tissue plasminogen activator for chronologically separate ischemic strokes does not appear to be associated with severe immune reactions. Larger case numbers are needed to evaluate safety and efficacy of repeated systemic thrombolysis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/STROKEAHA.110.585067 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful Rescue of Ventricular Fibrillation Electrical Storm Secondary to Acute Myocardial Infarction in a Patient Presenting to a District General Hospital: A Case Report.
Cureus
November 2024
Interventional Cardiology, Hull University Teaching Hospital National Health Service Trust, Hull, GBR.
Ventricular arrhythmia is a critical and challenging cardiovascular complication of myocardial infarction (MI). An electrical storm (ES), characterised by three or more episodes of sustained ventricular arrhythmia within 24 hours, poses a significant life-threatening risk. Standard management includes advanced life support (ALS) protocols and specialised pharmacological interventions.
View Article and Find Full Text PDFThe safety and efficacy of NeVa mechanical thrombectomy device in acute ischemic stroke: A systematic review and meta-analysis.
J Clin Neurosci
December 2024
Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston MA, USA. Electronic address:
Background: Recent favorable cohort studies on endovascular therapy for ischemic stroke have predominantly utilized NeVa thrombectomy (NeVa stent retrievers. We carried out a systematic review and meta-analysis to investigate the efficacy and safety of this second-generation stent retriever in acute ischemic stroke patients.
Method: We conducted the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Exceptional improvement in chronic stroke through Guided Self-rehabilitation Contract: a case report study.
Front Rehabil Sci
September 2024
AP-HP, Service de Rééducation Neurolocomotrice, Unité de Neurorééducation, Hôpitaux Universitaires Henri Mondor, Créteil, France.
Article Synopsis
- * After 16 months, she initiated a guided self-rehabilitation program where a therapist prescribed specific stretching and movement exercises targeting seven muscle groups to help regain function in her left arm.
- * Over four years, she consistently practiced the rehabilitation exercises for over two hours daily and fully regained use of her left arm, returning to work as a nurse's aide, with brain imaging confirming motor activity in her primary motor areas during left-hand use.
Subacute in-stent thrombosis after carotid artery stenting in a patient with gene polymorphisms associated with aspirin and clopidogrel resistance: a case report.
Thromb J
October 2024
Neurological Disease Center, Zigong Fourth People's Hospital, Zigong, 643000, Sichuan, China.
Article Synopsis
- Carotid artery stenting (CAS) is a treatment for narrowing arteries, but it can have a rare and serious complication called carotid stent thrombosis (CST).
- A case was studied where a 50-year-old man had CST after getting CAS and had trouble because of blood flow issues caused by a clot.
- Doctors used special treatments to remove the clot, and after changing his medications, he got better and didn’t have any new problems for over a year.
BASILAR ARTERY REOCCLUSION WITHIN 24 HOURS AFTER MECHANICAL THROMBECTOMY SUCCESSFULLY TREATED WITH NEW INTERVENTION.
Acta Clin Croat
November 2023
Department of Neurology, Faculty of Medicine in Novi Sad, University of Novi Sad, Novi Sad, Serbia.
Article Synopsis
- A healthily 37-year-old male experienced BAO symptoms just 30 minutes after the onset, following a recent COVID-19 vaccination, and underwent two mechanical thrombectomy procedures within 24 hours due to reocclusion.
- The patient showed significant improvement after repeated treatments, leaving the hospital with a low NIHSS score, indicating good recovery potential following rehabilitation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!